HLA class I antigen and PD-L1 expression are known to play a key role in the host immune response to tumor antigens, since the former is crucial for processing tumor antigens and presentation of tumor antigen derived peptides to cognate T cells, while the latter inhibits T cell activation (19, 20, 53, 55). This evidence concerns the gene CD274 and neoplasm.